View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Tilray Medical bringt erste in Deutschland angebaute kommerzielle medi...

Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und medizinischen Fachkräften stärkt, um fundierte, individuelle Gesundheitsentscheidungen zu treffen, hat heute die Markteinführung seiner ersten kommerziellen, in Deuts...

 PRESS RELEASE

Tilray Medical lance ses premiers produits commerciaux à base de canna...

Tilray Medical lance ses premiers produits commerciaux à base de cannabis thérapeutique « cultivés en Allemagne » dans le cadre de son autorisation de culture récemment étendue NEUMÜNSTER, Allemagne, 14 nov. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray Brands ») (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de la santé de prendre ensemble des décisions de santé individualisées éclairées, a annoncé aujourd’hui le lancement de ses premières fleurs de cannabis thérapeutique ...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of BlackRock MuniYield Pennsylvania Quality Fund and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 November 2024 in which we reassessed the appropriateness o...

 PRESS RELEASE

Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer Amer...

Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- , Long Island’s original craft brewery and a subsidiary of Tilray Brands (NASDAQ: TLRY and TSX: TLRY), proudly announces Blitz Beer, a refreshing new American Lager added to Blue Point’s winter seasonal lineup. Available November through February, Blitz Beer offers a crisp, sessionable profile perfect for colder months and festive gatherings. New York has a rich tradition of brewing exceptional American l...

 PRESS RELEASE

Tilray Medical Launches its First Commercial “Grown in Germany” Medica...

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the launch of its first commercial German grown medical cannabis flowers from its Aphria RX GmbH (“Aphria RX”) facility...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nuveen New Jersey Quality Muni Income Fd and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 November 2024 in which we reassessed the appropriateness of the...

 PRESS RELEASE

Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party

Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party Join 10 Barrel Brewing for a Free Community Event Celebrating the Snowboard Season with Live Music, Giveaways, and the Premiere of the "Beer Lodge" film at 10 Barrel’s Winter Party BEND, Ore., Nov. 13, 2024 (GLOBE NEWSWIRE) -- . (“10 Barrel Brewing” or “10 Barrel”), a pioneering craft brewery and subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to announce the , a free, all-ages event celebrating the festivities of the winter season, community, and of course, great beer. The event will take ...

 PRESS RELEASE

Breckenridge Distillery's Latest Creation is the Perfect Addition to Y...

Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka BRECKENRIDGE, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), releases its new for the holiday season. Whether enjoyed neat, on the rocks, or as the star ingredient of a favorite holiday cocktail, Breckenridge Distillery’s Candy Cane Vodka brings holiday cheer to those aged 21 and up and is now available in retailers nationwide. is 80 proof / 40% ABV...

 PRESS RELEASE

Experience the Ultimate 420 Festival Celebration with SweetWater's 20t...

Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025 ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- , (“SweetWater Brewing” or “SweetWater”), the hottest craft brewer in Atlanta and the largest in the Southeast, a subsidiary of Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY), has unveiled the headliners for the 2025 , marking the festival’s 20th anniversary with an epic celebration of music, cultur...

Opko Health Inc: 1 director

A director at Opko Health Inc bought 280,183 shares at 1.505USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 9, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: November 8, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabi...

Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabisextrakt bei durch Chemotherapie induziertem Erbrechen bekannt SYDNEY, Australien, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray Brands“) (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und Ärzten stärkt, um informierte, individuelle Gesundheitsentscheidungen zu treffen, freut sich, die Endergebnisse einer neuen wissenschaftlichen Studie mit dem Titel „Oral Cannabis Ext...

 PRESS RELEASE

Tilray Medical annonce les résultats positifs d’une étude sur l’extrai...

Tilray Medical annonce les résultats positifs d’une étude sur l’extrait de cannabis oral dans le traitement des vomissements induits par la chimiothérapie SYDNEY, Australie, 07 nov. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc., ci-après « Tilray Brands » (NASDAQ : TLRY et TSX : TLRY) et leader mondial du cannabis thérapeutique, qui permet aux patients et aux professionnels de la santé de prendre ensemble des décisions de santé individualisées éclairées, se réjouit d’annoncer les conclusions finales de la nouvelle étude scientifique conduite par son équipe i...

 PRESS RELEASE

OPKO Health Reports Third Quarter 2024 Business Highlights and Financi...

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2024. Highlights from the third quarter of 2024 and recent weeks include the following: Completed sale of select assets of BioReference Health to Labcorp for $237.5 million. OPKO completed the sale of BioReference Health’s laboratory testing businesses focused on clinical diagn...

 PRESS RELEASE

Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engag...

Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The ...

 PRESS RELEASE

Tilray Medical Announces Positive Results from Study on Oral Cannabis ...

Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the final results of a new scientific study their team has supported titled, "Oral Cannabis Extract for Secondary Prevention of Chemotherapy...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch